166 related articles for article (PubMed ID: 28259425)
1. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.
Rúa-Figueroa Í; Richi P; López-Longo FJ; Galindo M; Calvo-Alén J; Olivé-Marqués A; Loza-Santamaría E; Vicente SP; Erausquin C; Tomero E; Horcada L; Uriarte E; Sánchez-Atrio A; Rosas J; Montilla C; Fernández-Nebro A; Rodríguez-Gómez M; Vela P; Blanco R; Freire M; Silva L; Díez-Álvarez E; Ibáñez-Barceló M; Zea A; Narváez J; Martínez-Taboada V; Marenco JL; de Castro MF; Fernández-Berrizbeitia O; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas JJ; Pecondón Á; Marras C; Carreira P; Bonilla G; Torrente V; Castellví I; Alegre J; Moreno M; Raya E; de la Peña PG; Vázquez T; Aguirre Á; Quevedo V; Pego-Reigosa JM;
Medicine (Baltimore); 2015 Jan; 94(1):e267. PubMed ID: 25569641
[TBL] [Abstract][Full Text] [Related]
3. The effect of smoking on cumulative damage in systemic lupus erythematosus: An incident cohort study.
McKown T; Schletzbaum M; Unnithan R; Wang X; Ezeh N; Bartels CM
Lupus; 2021 Apr; 30(4):620-629. PubMed ID: 33470148
[TBL] [Abstract][Full Text] [Related]
4. Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
Nieto R; Quintana R; Zavala-Flores E; Serrano R; Roberts K; Catoggio LJ; García MA; Berbotto GA; Saurit V; Bonfa E; Borba EF; Lavras Costallat LT; Da Silva NA; Sato EI; Tavares Brenol JC; Massardo L; Neira OJ; Vázquez G; Guibert Toledano M; Pascual-Ramos V; Sauza Del Pozo MJ; Barile-Fabris LA; Amigo MC; García De La Torre I; Acevedo-Vásquez EM; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA; Pons-Estel GJ
Lupus; 2024 Apr; 33(4):340-346. PubMed ID: 38334100
[TBL] [Abstract][Full Text] [Related]
5. Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort.
Nguyen Y; Blanchet B; Urowitz MB; Hanly JG; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; Van Vollenhoven RF; Aranow C; Le Guern V; Mackay M; Ruiz-Irastorza G; Lim SS; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Buyon J; Costedoat-Chalumeau N
Arthritis Rheumatol; 2023 Dec; 75(12):2195-2206. PubMed ID: 37459273
[TBL] [Abstract][Full Text] [Related]
6. Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
Bernatsky S; Ramsey-Goldman R; Joseph L; Boivin JF; Costenbader KH; Urowitz MB; Gladman DD; Fortin PR; Nived O; Petri MA; Jacobsen S; Manzi S; Ginzler EM; Isenberg D; Rahman A; Gordon C; Ruiz-Irastorza G; Yelin E; Bae SC; Wallace DJ; Peschken CA; Dooley MA; Edworthy SM; Aranow C; Kamen DL; Romero-Diaz J; Askanase A; Witte T; Barr SG; Criswell LA; Sturfelt GK; Blanco I; Feldman CH; Dreyer L; Patel NM; St Pierre Y; Clarke AE
Ann Rheum Dis; 2014 Jan; 73(1):138-42. PubMed ID: 23303389
[TBL] [Abstract][Full Text] [Related]
7. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.
Pons-Estel GJ; Alarcón GS; González LA; Zhang J; Vilá LM; Reveille JD; McGwin G;
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):393-400. PubMed ID: 20391486
[TBL] [Abstract][Full Text] [Related]
8. Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.
Li XB; Cao NW; Chu XJ; Zhou HY; Wang H; Yu SJ; Ye DQ; Li BZ
Ann Med; 2021 Dec; 53(1):1687-1695. PubMed ID: 34553648
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hospitalization in Mexican patients with systemic lupus erythematosus.
García-Cañas IE; Cuevas-Orta E; Herrera-Van Oostdam DA; Abud-Mendoza C; Group L
Lupus; 2024 Jul; 33(8):892-898. PubMed ID: 38670796
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for initial and recurrent severe infections in first hospitalized patients with systemic lupus erythematosus: A retrospective study of a Chinese cohort.
Zhu Y; Zhu K; Zhang X; Qian Z; Guo Q; Xu X; Yao G; Tang X; Wang D; Zhang H; Feng X; Jin Z; Sun L
Int J Rheum Dis; 2024 Apr; 27(4):e15131. PubMed ID: 38563679
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors and Incidence of Serious Infections in Patients With Systemic Lupus Erythematosus Undergoing Rituximab Therapy.
Sun YS; Huang DF; Chen WS; Liao HT; Chen MH; Tsai MT; Yang CY; Lai CC; Tsai CY
J Rheumatol; 2024 Feb; 51(2):160-167. PubMed ID: 37839817
[TBL] [Abstract][Full Text] [Related]
12. Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII).
Burgos PI; McGwin G; Reveille JD; Vilá LM; Alarcón GS
Rheumatology (Oxford); 2010 Sep; 49(9):1720-5. PubMed ID: 20498010
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality.
Icen M; Nicola PJ; Maradit-Kremers H; Crowson CS; Therneau TM; Matteson EL; Gabriel SE
J Rheumatol; 2009 Jan; 36(1):50-7. PubMed ID: 19004043
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
Ichinose K; Sato S; Igawa T; Okamoto M; Takatani A; Endo Y; Tsuji S; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Yajima N; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Sato S; Fujiwara M; Kawakami A
Arthritis Res Ther; 2024 Feb; 26(1):48. PubMed ID: 38347556
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and prognosis of systemic lupus erythematosus complicated by active cytomegalovirus infection: a retrospective cohort study.
Chen Y; Zhang L; Liu Y; Liu Y; Zhao L; Zhou B; Ruan G; Shi X; Liu X
Front Immunol; 2024; 15():1323923. PubMed ID: 38481991
[TBL] [Abstract][Full Text] [Related]
16. Non-thyroidal disease syndrome in patients with systemic lupus erythematosus: relation to disease inflammatory activity.
Meng X; Lv A; Tang M; Liu X; Wang X; Li Y; Chai Y; Yang Q; Kou C; Zhang L; Li M; Zhang H
Clin Rheumatol; 2024 May; 43(5):1551-1558. PubMed ID: 38578510
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study.
Zhang L; Zou X; Jiang N; Xie L; Liu J; Yang Z; Cao Q; Li C; Sun X; Zhang F; Zhao Y; Zeng X; Shi X; Liu X;
Front Immunol; 2023; 14():1157157. PubMed ID: 37388724
[TBL] [Abstract][Full Text] [Related]
18. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
Rua-Figueroa I; García de Yébenes MJ; Martinez-Barrio J; Galindo Izquierdo M; Calvo Alén J; Fernandez-Nebro A; Menor-Almagro R; Carmona L; Tejera Segura B; Tomero E; Freire-González M; Sangüesa C; Horcada L; Blanco R; Uriarte Itzazelaia E; Narváez J; Rosas Gómez de Salazar JC; Gómez-Sabater S; Morales CM; Andreu JL; Segarra VT; Aurrecoechea E; Perez A; Nóvoa Medina J; Salgado E; Lozano-Rivas N; Montilla C; Ruiz-Lucea E; Arevalo M; Iñiguez C; García-Villanueva MJ; Exposito L; Ibáñez-Barceló M; Bonilla G; Carrión-Barberà I; Erausquin C; Fragio Gil JJ; Pecondón A; Toyos FJ; Cobo T; Muñoz-Jiménez A; Oller J; Nolla JM; Pego-Reigosa JM
Lupus Sci Med; 2024 Apr; 11(1):. PubMed ID: 38589223
[TBL] [Abstract][Full Text] [Related]
19. Deep Neck Infection in Systemic Lupus Erythematosus Patients: Real-World Evidence.
Chang GH; Su YC; Lin KM; Liu CY; Yang YH; Chang PJ; Lin MH; Lee CP; Hsu CM; Tsai YT; Wu CY; Tsai MS
Sci Rep; 2020 Mar; 10(1):4133. PubMed ID: 32139803
[TBL] [Abstract][Full Text] [Related]
20. Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus.
Bruera S; Lei X; Zhao H; Yazdany J; Chavez-MacGregor M; Giordano SH; Suarez-Almazor ME
Lupus Sci Med; 2023 Feb; 10(1):. PubMed ID: 36787921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
